Endocrinology Vol. 140, No. 12 5982-5990
Copyright © 1999 by The Endocrine Society
Tyrosine Phosphorylation and Subcellular Localization of Focal Adhesion Proteins during in Vitro Decidualization of Human Endometrial Stromal Cells
Tetsuo Maruyama1,
Yasunori Yoshimura and
Hisataka Sabe2
Department of Obstetrics and Gynecology, Keio University School of
Medicine (T.M., Y.Y.), Tokyo 160-0016, Japan; and the Department of
Biological Responses, Institute for Virus Research, Kyoto University
(T.M., H.S.), Kyoto 606-8397, Japan
Address all correspondence and requests for reprints to: Dr. Tetsuo Maruyama, Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-0016, Japan. Fax: 81-3-3226-1667.
 |
Abstract
|
|---|
Human endometrial stromal cells undergo in vitro
decidualization when treated with progesterone and estrogen. Using this
model, we previously reported specific changes in the c-Src kinase
activity and tyrosine phosphorylation of several proteins during
in vitro decidualization. Focal adhesion kinase (FAK)
and paxillin are known to form a complex with c-Src at the focal
contacts and to participate in the integrin-mediated signal
transduction as c-Src substrates. We here examined the tyrosine
phosphorylation and subcellular localization of the focal adhesion
proteins in stromal cells isolated from human endometrium. We found,
however, that the total levels of FAK and paxillin tyrosine
phosphorylation were not markedly changed during decidualization or
after steroid withdrawal. In our culture system, numerous multicellular
nodules were developed in cultures of decidualized stromal cells,
within whose nodules the focal contacts were found to disappear.
Moreover, disruption of the focal contacts was accompanied by
disorganization of the actin-based cytoskeleton. These findings suggest
that tyrosine phosphorylation of the endometrial paxillin and FAK is
not tightly regulated by the kinase activity of c-Src during in
vitro decidualization. The escape from regulation by
c-Src may be in part due to the dissociation of the focal adhesion
proteins/c-Src complex caused by the breakdown of the focal adhesion
plaques as well as the loss of the actin-based cytoskeletal
architecture.
 |
Introduction
|
|---|
INTEGRINS, a family of cell surface
ß
heterodimeric transmembrane glycoprotein receptors, are one of the
structural components of focal adhesions that are sites of tight
adhesion to the underlying extracellular matrix (ECM) (1, 2). The
aggregation of integrins upon cell to ECM attachment activates the
focal adhesion kinase (FAK) and leads to the assembly of a
multicomponent signaling complex including vinculin,
-actinin,
paxillin, cortactin, talin, and tensin (2, 3, 4, 5). Src family tyrosine
kinases such as c-Src and Fyn, which are also included in the focal
adhesion complex, participate in this integrin-mediated signal
transduction. These kinases modulate the activity and recruitment of
the focal adhesion proteins and eventually affect the actin-based
cytoskeletal organization (2, 3, 4, 5). Alterations in integrin-mediated cell
adhesion to the ECM are essential regulatory processes during
development, cell growth and differentiation, migration, apoptosis, and
oncogenesis (1).
Recently, integrins have been implicated in a variety of biological
processes in reproduction (6, 7, 8). Various types of integrins are
temporally and spatially expressed in the endometrium during the
implantation window (9, 10) and in the embryo and the surrounding
trophoblast (11). Additionally, the inhibitory effects of antiintegrin
antibodies on embryo attachment and outgrowth onto the endometrium (12, 13) indicate a pivotal role of integrins in implantation. Also,
integrins may be involved in endometrial tissue remodeling by
regulating the integrity of cell to cell and/or cell to ECM interaction
(7, 8). For example, integrin ß1 is preferentially
expressed in the pregnancy decidua in vivo, and its
expression level is increased during in vitro
decidualization of endometrial stromal cells (ESC) (8, 10, 14),
suggesting the importance of integrin ß1 in decidual
transformation. However, the role of integrins and focal adhesion
proteins in decidualization remains unclear.
We previously reported that the kinase activity of c-Src is elevated
and accompanied by changes in tyrosine phosphorylation of several
cellular proteins during in vitro decidualization (15).
Focal adhesion proteins, including FAK and paxillin, are deeply
involved in the integrin-mediated signal transduction through focal
adhesion assembly, serving as substrates for the Src family tyrosine
kinases (2, 3, 4, 5). This knowledge prompted us to determine whether
activation of an integrin-mediated signaling pathway(s) using FAK and
paxillin is a downstream event of the decidual c-Src activation.
Endometrial cells differentially express many types of integrins in the
process of decidualization (8, 10, 14). Moreover, human and rodent ESC
up- and down-regulate various types of ECM during in vivo
and in vitro decidualization (16, 17, 18, 19, 20), thereby changing the
composition of cell to cell and cell to ECM adherence. Taken together,
it is likely that alterations in ECM components may activate
decidualization-specific signaling cascades involving c-Src and focal
adhesion proteins through ECM/integrin interaction, ultimately leading
to the morphological and functional decidual transformation. Therefore,
to investigate the c-Src-mediated signaling pathway responsible for
decidualization, we here focused on analyzing tyrosine
phosphorylation and subcellular localization of focal adhesion proteins
such as paxillin and FAK.
 |
Materials and Methods
|
|---|
Antibodies
Antiphosphotyrosine antibody 4G10 (mouse, monoclonal) and Z-PY1
(rabbit, polyclonal) were obtained from Upstate Biotechnology, Inc. (Lake Placid, NY) and Zymed Laboratories, Inc.
(South San Francisco, CA), respectively. Antipaxillin monoclonal
antibody was purchased from Transduction Laboratories, Inc. (Lexington, KY). Antivinculin antibody was obtained from
Sigma Chemical Co. (St. Louis, MO). Fluorescein
isothiocyanate (FITC)-conjugated phalloidin was purchased from
Molecular Probes, Inc. (Eugene, OR). Anti-FAK polyclonal
antibody was raised against the
glutathione-S-transferase-fused C-terminal one third region
of mouse FAK as described previously (21).
Isolation of ESC and hormonal treatment
Human endometria were obtained as described previously (15, 22).
Three additional endometria obtained from premenopausal women without
any history of gynecological malignancy were subjected to FAK and
paxillin immunoprecipitation and immunocytochemical studies. Informed
consent was obtained from all subjects.
Isolation and hormonal treatment of ESC were performed as previously
described (15, 22). In brief, isolated ESC were cultured and grown to
subconfluence in the basal medium: phenol red-free RPMI 1640
supplemented with 10% charcoal-stripped FCS and 1%
antibiotic-antimycotic mixture (Life Technologies, Inc.,
Grand Island, NY). After 2 days of preculture, the medium was replaced
with fresh basal medium containing 10 nM 17ß-estradiol
(E2), 1 µM progesterone (P), 10
nM E2 plus 1 µM P, or
0.1% ethanol as control vehicles. The culture medium containing the
hormones was renewed every 2 days. For hormone withdrawal experiments,
ESC that had been treated with E2 and P for 14
days were washed and cultured with or without E2
and P for an additional 4 days.
Immunoprecipitation and immunoblotting with antiphosphotyrosine,
paxillin, and FAK antibodies
Cell lysates were prepared with radioimmunoprecipitation
buffer as previously described (15, 22). The protein concentration of
the samples was measured by the DC protein assay kit (Bio-Rad Laboratories, Inc., Cambridge, MA). Immunoprecipitation and
Western immunoblotting were performed as previously described (15). In
brief, 100200 µg cell lysates were immunoprecipitated by incubation
with paxillin or FAK antibody for 120 min at 4 C, followed by addition
of 20 µl protein G-Sepharose beads (Sigma Chemical Co.)
for 60 min. Immune complexes were washed three times with
radioimmunoprecipitation buffer and then resuspended in 2
x SDS sample buffer. The samples were subjected to SDS-PAGE,
transferred to Immobilon (Millipore Corp., Bedford, MA),
and detected by incubating the blots with the specified antibody.
Immunoblots were incubated with either goat antirabbit or antimouse
horseradish peroxidase-conjugated antibodies and developed using an
enhanced chemiluminescence kit according to the manufacturers
procedure (Amersham Pharmacia Biotech, Arlington Heights,
IL). When indicated, immunoblots were stripped in the buffer [62.5
mM Tris (pH 6.8), 2% SDS, and 100 mM
ß-mercaptoethanol] at 50 C for 30 min and reprobed with another
specific antibody.
Immunofluorescence and confocal laser microscopy
The isolated ESC, obtained as previously described (15, 22),
were seeded and grown on plastic chamber slides (Permanox, Lab-Tek
Chamber Slide, Nunc, Roskilde, Denmark) to subconfluence. Subsequently,
the cells were treated with or without E2 and/or
P for 7 days. Cells were then fixed in 3.7% formaldehyde in PBS for 20
min at room temperature and permeablized with 0.5% Triton X-100 in PBS
at room temperature. After they were blocked by 10% FCS in PBS for 30
min at room temperature, slides were incubated with either antipaxillin
(1:250) or antivinculin antibody (1:400) for 90 min at 37 C. After
being washed three times in PBS, bound antibodies were visualized using
fluorescein-conjugated antibody for 30 min at 37 C in a moist
chamber. For double staining of filamentous actin (F-actin) and either
paxillin or vinculin, fluorescein-conjugated phalloidin was included
with a secondary rhodamine-conjugated antimouse antibody. The slides
were washed extensively in PBS and mounted. The confocal images as
shown in Fig. 4
were collected with a laser scanning microscope system
(LSM-GB, Olympus Corp., Tokyo, Japan), as described
previously (23, 24), under the following conditions: object lens,
Olympus Corp. Splan-Apo x60 (numerical aperture =
1.4); zoom ratio, x 2.0. The other confocal images as shown in Fig. 5
were taken using the MRC-600 Laser Scanning Confocal Imaging System
(Bio-Rad Laboratories, Inc., Cambridge, MA) connected to a
Carl Zeiss Axiplan compound microscope (New York, NY).

View larger version (87K):
[in this window]
[in a new window]
|
Figure 4. Disappearance of the focal contacts in the
decidualization-induced multicellular nodules. Isolated ESC treated
with control vehicles (A), E2 (B), P (C), or E2
plus P (D and E) for 7 days were immunostained with antipaxillin
antibody. The first antibody was visualized by FITC-conjugated
secondary antibody. The laser scanning confocal microscopy
(Olympus Corp. LSM-GB) optically sectioned labeled
multicellular nodules in cultures of decidualized ESC. The panel of
focus in D was toward the substratum of the nodules, whereas the
section shown in E was taken at the middle of nodules as indicated.
Bars, 25 µm.
|
|

View larger version (70K):
[in this window]
[in a new window]
|
Figure 5. Disorganization of actin-based cytoskeleton in the
decidualization-induced multicellular nodules. Isolated ESC treated
with or without E2 and P as indicated for 7 days were
double stained for F-actin using FITC-conjugated-phalloidin and for
either paxillin or vinculin using the corresponding monoclonal antibody
that was subsequently visualized by rhodamine-conjugated secondary
antibody. A, Paxillin (upper left panel), F-actin
(middle left panel), and both merged immunostaining
(lower left panel) in the multicellular nodules
developed during E2- and P-induced decidualization. The
two right panels showed double labeled immunostaining
for F-actin and paxillin in the untreated ESC. Bars in
the left panels, 50 µm. Magnification in the
two right panels, x1000. B, Vinculin (two upper
panels), F-actin (two middle panels), and both
merged immunostaining (two lower panels) in the
multicellular nodules developed during E2- and
P-induced decidualization (three left panels)
vs. that in the untreated ESC (three right
panels). The two micrographs in the right panels
in A were taken using the conventional immunofluorescence microscope,
whereas all other photographs in A and B were taken using the MRC-600
Laser Scanning Confocal Imaging System (Bio-Rad Laboratories, Inc.). Bars in the left and
right panels, 50 and 25 µm, respectively.
|
|
 |
Results
|
|---|
No marked alterations in tyrosine phosphorylation levels of
paxillin and FAK during decidualization
To understand how the activation of c-Src is involved in
decidualization in vitro, we examined tyrosine
phosphorylation of paxillin and FAK, which are known to be in
vivo and in vitro substrates for c-Src (2, 3, 4, 5). As shown
in Fig. 1A
, the whole pattern of tyrosine
phosphorylation of cellular proteins was changed during
E2- and P-induced decidualization as reported
previously (15). A thick approximately 60-kDa band was clearly observed
in ESC treated with control vehicles throughout the culture period
(Fig. 1A
, upper panel, lanes 1, 3, and 13, white
arrowheads), whereas the intensity of this band was decreased as
ESC underwent decidualization (Fig. 1A
, upper panel, lanes
2, 4, and 15). In contrast, an approximately 56-kDa band whose tyrosine
phosphorylation was not detected in undifferentiated ESC (Fig. 1A
, upper panel, lanes 1, 3, and 13), became phosphorylated
during decidualization (upper panel, lanes 2, 4, and 15,
gray arrowheads). It remains to be solved whether each band
of several tyrosine-phosphorylated proteins, including the
approximately 60- and 56-kDa proteins represents a single protein.
However, we previously provided strong evidence suggesting that the
dephosphorylated, approximately 60-kDa band is c-Src (15).

View larger version (66K):
[in this window]
[in a new window]
|
Figure 1. Tyrosine phosphorylation of FAK and paxillin
in the hormonally treated ESC. A, Immunoblotting data of whole cell
lysates derived from hormonally treated ESC and immunoprecipitates with
anti-FAK or antipaxillin antibody. Isolated ESC were treated with
control vehicles (Cx; lanes 1, 3, 5, 7, 9, 11, 13, 16, and 19),
E2 (lanes 14, 17, and 20), or E2 plus P (lanes
2, 4, 6, 8, 10, 12, 15, 18, and 21) for 3 days (lanes 1, 2, 5, 6, 9,
and 10), 7 days (lanes 3, 4, 7, 8, 11, and 12), and 14 days (lanes
1321), and then the cells were harvested. Whole cell lysates were
prepared, and immunoprecipitation was performed as described in
Materials and Methods. The cell lysates (Input: lanes
14 and 1315) and immunoprecipitates with either anti-FAK antibody
(IP: anti-FAK; lanes 912 and 1921) or antipaxillin antibody (IP:
anti-paxillin; lanes 58 and 1618) were subjected to SDS-PAGE and
immunoblotting with antiphosphotyrosine antibody 4G10 (anti-PY;
upper panel). Blots were stripped and reprobed with
anti-FAK antibody (middle panel), and then stripped
again and reprobed with antipaxillin antibody (lower
panel). White arrowheads,
Tyrosine-phosphorylated, approximately 60-kDa protein(s); gray
arrowheads, tyrosine-phosphorylated, approximately 56-kDa
protein(s); black arrowheads, IgG heavy chains;
gray arrows, tyrosine-phosphorylated paxillin;
black arrows, tyrosine-phosphorylated FAK. The depicted
blot is representative of similar three independent experiments using
different endometrial samples including two samples used in the
previous study (15 ). B, Immunoblotting data of whole cell lysates and
paxillin immunoprecipitates derived from hormonally treated ESC as
indicated. Blots were stripped and reprobed with antipaxillin antibody
(lower panel) after the first blot with anti-PY antibody
Z-PY1 (upper panel). Gray arrows,
Tyrosine-phosphorylated paxillin. A total of two independent similar
experiments were conducted, and the results from one representative
experiment are shown.
|
|
Despite the alterations in the entire pattern of tyrosine
phosphorylation, no dramatic changes in phosphorylation were seen in
the 125-kDa FAK immunoprecipitates upon hormonal treatment (Fig. 1A
, upper panel, lanes 912 and 1921, black
arrows). The intensity of the phosphorylation signal appeared to
correlate with the protein amount of the corresponding
immunoprecipitate (Fig. 1A
, lanes 912 and 1921 in upper panel
vs. middle panel). The level of FAK expression was
clearly constant throughout the culture (Fig. 1A
, middle
panel, lanes 14 and 1315).
Similarly, the phosphorylation level of the 68-kDa paxillin
immunoprecipitate was almost constant throughout the culture period
(Fig. 1A
, upper panel, lanes 58 and 1618, gray
arrows). Although the level of paxillin expression appeared to
slightly increase during decidualization (Fig. 1A
, lower
panel, compare lane 1 with 2 and lane 13 with 15), no significant
induction of paxillin was observed in the other two independent sets of
similar experiments (Fig. 1B
, lower panel, lanes 912; data
not shown). In the lower panel of Fig. 1A
, the signals of
some paxillin immunoprecipitates were weak (lanes 7, 8, and 18), which
might be caused by partial disruption of the paxillin blots from the
membrane due to the repeated stripping and reprobing procedure. To
further investigate the phosphorylation level of paxillin in hormonally
treated ESC, the other independent set of similar experiments was
performed as shown in Fig. 1B
. These results clearly demonstrated that
the phosphorylation levels of the paxillin immunoprecipitates (Fig. 1B
, upper panel, lanes 18 and 1316, gray arrows)
and the protein amount of the immunoprecipitable paxillin (lower
panel, lanes 18 and 1316) were not markedly changed upon
hormonal treatment and thereafter during decidualization.
E2 alone did not provoke any change in the whole
pattern of tyrosine phosphorylation or in the phosphorylation levels of
FAK and paxillin (Fig. 1A
, lanes 14, 17, and 20; Fig. 1B
, lanes 2, 6,
and 14), compared with the control treatment (Fig. 1A
, lanes 13, 16,
and 19; Fig. 1B
, lanes 1, 5, and 13).
No marked alterations in tyrosine phosphorylation levels of
paxillin and FAK upon steroid withdrawal
We previously reported that withdrawal of both estrogen and
progesterone from cultures of decidualized ESC reduces c-Src kinase
activity to the basal level, concomitantly reversing the tyrosine
phosphorylation pattern to the unstimulated state (15). As FAK and
paxillin are downstream targets of c-Src (2, 3, 4, 5), we further determined
whether tyrosine phosphorylation of FAK and paxillin was changed in
response to steroid withdrawal. As shown in Fig. 2
, phosphorylated, approximately 64- and
56-kDa bands disappeared upon steroid withdrawal (upper
panel, lanes 1 and 2, gray arrowheads), whereas the
approximately 60-kDa band became phosphorylated (upper
panel, lanes 1 and 2, white arrowheads). These changes
in the whole pattern of tyrosine phosphorylation are consistent with
the previous results (15). Although the phosphorylation signals of FAK
and paxillin immunoprecipitates seemed to become weak upon steroid
withdrawal (Fig. 2
, upper panel, lanes 36), the decrease
in the phosphorylation level correlated with that in the protein amount
of the corresponding immunoprecipitates (middle panel, lanes
5 and 6; lower panel, lanes 3 and 4). Thus, steroid
withdrawal also did not markedly affect the tyrosine phosphorylation
status of FAK and paxillin.

View larger version (52K):
[in this window]
[in a new window]
|
Figure 2. Tyrosine phosphorylation of FAK and paxillin upon
steroid withdrawal. Isolated ESC were treated with E2 and P
for 14 days to allow them to become fully decidualized. Subsequently,
the cells were washed, cultured with or without E2 and P
for further 4 days (E2 + P and Withdrawal, respectively),
and then harvested. Whole cell lysates were prepared, and
immunoprecipitation with either antipaxillin or anti-FAK antibody was
performed as described in Materials and Methods. The
samples were subjected to SDS-PAGE and immunoblotting with 4G10
(upper panel). Blots were stripped and reprobed with
anti-FAK antibody (middle panel) and thereafter again
stripped and reprobed with antipaxillin antibody (lower
panel). Gray arrowheads,
Tyrosine-phosphorylated, approximately 64-kDa and approximately 56-kDa
proteins; white arrowhead, tyrosine-phosphorylated,
approximately 60-kDa protein(s); black arrowheads, IgG
heavy chains; gray arrow, tyrosine-phosphorylated
paxillin; black arrow, tyrosine-phosphorylated FAK. A
total of two independent similar experiments were conducted using two
different endometrial samples, including one used in the previous study
(15 ), and the result from one representative experiment is shown.
|
|
Development of numerous multicellular nodules during in vitro
decidualization
In our culture system, untreated ESC remain flattened throughout
the duration of the cultures (Fig. 3A
).
In contrast, E2- plus P-treated ESC became
rounded and densely packed, and gave rise to multicellular nodules
(Fig. 3B
). As shown in the phase contrast micrographs under the lower
magnification (Fig. 3
, C and D), numerous nodules were dominant in
cultures of decidualized ESC (Fig. 3D
), whereas no apparent nodules
were observed in the control cultures (Fig. 3C
).

View larger version (142K):
[in this window]
[in a new window]
|
Figure 3. Development of numerous multicellular nodules
during in vitro decidualization of ESC. Phase contrast
micrographs of isolated ESC cultured for 14 days with control vehicles
(A and C) or with E2 and P (B and D). Photographs were
taken under x100 magnification (A and B) and x40 magnification (C and
D).
|
|
Loss of focal adhesion plaques in the decidualization-induced
multicellular nodules
The formation of focal adhesions is prerequisite for the
integrin-mediated signaling pathways responsible for cell growth,
differentiation, migration, transformation, and contractility (2, 3, 5). To address the question of why tyrosine phosphorylation of FAK and
paxillin was not markedly changed despite decidual c-Src activation, we
next analyzed the subcellular localization of the focal adhesion
proteins focusing on the characteristic decidualization-induced
multicellular nodules. ESC in the control cultures clearly possessed
focal contacts, as assessed by the immunostaining of paxillin and
vinculin (Figs. 4A
and 5A
, two right panels;
and Fig. 5B
, three right panels). Although
E2 or P alone induced cell aggregation to some
extent, accumulation of paxillin in the focal adhesion plaques was not
decreased (Fig. 4
, B and C, respectively). The occasional monolayer
populations of E2- and P-treated ESC, located
between the multicellular nodules, also exhibited focal adhesions
containing paxillin and vinculin (data not shown). However, in the
multicellular nodules no discrete accumulations of paxillin staining
could be detected at borders of adjoining cells or at distinct focal
adhesion plaques; rather, paxillin was diffusely localized in the
cytosol (Fig. 4E
). However, in contrast, paxillin was localized in the
focal contacts in the substratum of those nodules (Fig. 4D
).
Disorganization of actin-based cytoskeleton in the
decidualization-induced multicellular nodules
The orderly recruitment and complex formation of focal adhesion
proteins are crucial for actin-based cytoskeletal organization (2, 3, 4, 5).
We further investigated the subcellular distribution of actin stress
fibers in the multicellular nodules where the formation of the focal
adhesion assembly was impaired. Double labeled immunostaining of ESC
using FITC-conjugated phalloidin and antipaxillin antibody, visualized
by rhodamine-conjugated secondary antibody, showed that the
undifferentiated and flattened ESC in the control cultures clearly
possessed focal adhesion contacts containing paxillin (Fig. 5A
, two right panels, yellow signals). Moreover, there were well
stretched actin stress fibers (Fig. 5A
, two right panels, green
signals) linking paired focal adhesion contacts (white
arrows). However, neither the typical subcellular distribution of
paxillin nor F-actin connecting focal adhesion plaques could be
detected within the multicellular nodules (Fig. 5A
, left
upper and middle panels, respectively). The merged
image showed considerable yellow signals mainly at borders of adjoining
cells (Fig. 5A
, lower left panel). Although it may suggest
the codistribution of some populations of cytosolic paxillin with
F-actin, it remains to be clarified whether the merged signals were due
to a real colocalization or a to simple overlapping of both signals at
the cell periphery. Similarly, in the undifferentiated ESC, vinculin
staining was observed at the focal contacts (Fig. 5B
, upper right
panel) with actin stress fibers (middle right panel)
connecting vinculin-containing focal adhesion plaques (lower
right panel, yellow signals). In the decidualization-induced
multicellular nodules, however, vinculin did not localize at distinct
focal contacts (Fig. 5B
, upper left panel), but was
diffusely localized in the cytosol (lower left panel, red
signals) and also localized at the cell periphery along with
F-actin (lower left panel, yellow signals).
 |
Discussion
|
|---|
The current paradigm of integrin/ECM-mediated signaling is that
the aggregation of integrins upon cell adhesion results in FAK
autophosphorylation, followed by the recruitment of Src/Fyn or Csk
through binding to the SH2 domains of these kinases (2). This complex,
in turn, phosphorylates paxillin on multiple sites, leading to
activation of the downstream signaling cascade (2). Src family tyrosine
kinases bound to FAK phosphorylate additional sites in FAK and thereby
stimulate FAK kinase activity (2, 4). Thus, Src family tyrosine kinases
act as potential regulators of the integrin-mediated signal
transduction involving FAK and paxillin at the focal contacts (2, 4).
In our culture system, the levels of FAK and paxillin phosphorylation
appeared to be constant during decidualization and thereafter upon
steroid withdrawal. Given our previous results showing activation of
c-Src during in vitro decidualization and its inactivation
upon steroid withdrawal (15), our present findings suggest that
tyrosine phosphorylation of FAK and paxillin may not be related to the
kinase activity of c-Src in decidualized ESC. This is in agreement with
the report by Schlaepfer et al., who demonstrated that the
activation of c-Src can be dissociated from FAK activation (25) and
that there are at least two separate downstream pathways (25). This
model may account for the c-Src-independent phosphorylation of the
endometrial FAK and paxillin as presented here. In addition, c-Src
interaction with FAK is known to be regulated by cell adhesion (5).
Given the observed breakdown of focal adhesion contacts in decidualized
ESC, it seems that dissociation of the c-Src/FAK focal adhesion complex
may take place during decidualization. Thus, FAK and paxillin are no
longer regulated by activated c-Src.
In contrast to the c-Src-FAK interaction, the paxillin-FAK interaction
has been reported to be constitutive and unaffected by integrin-ECM
interaction, i.e. the formation of focal adhesions (26). FAK
is believed to be a point of convergence in the actions of integrins
and growth factors (27, 28). In fact, FAK is not only activated by
integrins, but also by mitogenic neuropeptides (29), thrombin (30), and
ligands for tyrosine kinase receptors, such as platelet-derived growth
factor and hepatocyte growth factor (31, 32, 33). As ESC produce a large
number of growth factors during decidualization (34, 35), it is
possible that tyrosine phosphorylation of the decidual FAK and paxillin
may be regulated mainly by decidualization-associated growth factors
rather than by integrin/c-Src-mediated signaling pathways. In this
regard, decidualization might provoke a stepwise transition from
integrin mediated- to growth factor-dependent signaling pathway(s)
upstream of FAK and paxillin. This hypothesis may account for the
constant levels of FAK and paxillin phosphorylation during
decidualization despite the disruption of focal adhesions.
We have shown for the first time that there is a disorganization of the
actin-based cytoskeleton and a loss of focal adhesions within the
decidualization-associated multicellular nodules. The mechanism for
this disruption is unknown. In fibroblasts, activation of the
cAMP/PKA-mediated signaling pathway is known to disrupt focal adhesion
plaques as well as the actin-based cytoskeleton through down-regulation
of myosin light chain kinase (2, 36). Given that activation of the
cAMP/PKA pathway is one of the key events associated with
decidualization (37, 38, 39), this pathway may contribute to the
decidualization-induced disruption of the cytoskeleton. Carter et
al. reported that F-actin is reversibly disrupted in human ESC
expressing the temperature-sensitive simian virus 40 large T antigen
(40). Moreover, coexpression together with EJ ras oncogene
results in the localized reorganization of stress fibers near the cell
periphery (40). This pattern of subcellular F-actin distribution
appears to be similar, as observed here within decidualization-induced
multicellular nodules, in that F-actin was concentrated at the cell
periphery. Similar localization of actin microfilaments at the cell
periphery has been reported in a mouse in vitro
decidualization model (20). It is, therefore, of great interest to
determine whether the process of decidualization may involve Ras or
Ras-related proteins such as Rho (2), a small GTP-binding protein
potentially regulating the focal adhesion assembly and organization of
the actin-based cytoskeleton (2).
Recently, Kim et al. reported that cytochalasin
D-induced disruption of the actin-based cytoskeleton results in
increased expression of insulin-like growth factor-binding protein-1, a
typical decidualization-associated marker (41). They proposed the
hypothesis that alterations in the cytoskeleton are deeply involved in
insulin-like growth factor-binding protein-1 regulation (41). Although
treatment of ESC with cytochalasin D is artificial, our data support
the idea, in that breakdown of the cytoskeleton occurring during
in vitro decidualization together with the loss of focal
contacts may enhance the production of many bioactive substances by
ESC. The coincidence of the production of decidualization-associated
markers and the initiation of morphological decidual changes (15, 22, 42) also suggests a possible involvement of the cytoskeletal
organization in decidual function.
The present study is the first to follow the tyrosine phosphorylation
and subcellular distribution of focal adhesion proteins in hormonally
treated human ESC in vitro. Together with our previous
result indicating the elevation of c-Src kinase activity during
in vitro decidualization (15), our present data suggest that
c-Src may activate a different signaling pathway(s), which does not
involve FAK and paxillin, in decidualized ESC. Furthermore, it is
possible that dissociation of the focal adhesion complex together with
breakdown of the actin-based cytoskeleton might actively contribute
to both functional and morphological decidualization. In this regard,
it is conceivable that cytosolic free forms of focal adhesion proteins
may play a functional role in decidual transformation. Thus, further
investigation focusing on the endometrial integrins, focal adhesion
proteins, Src family tyrosine kinases, and actin-based cytoskeleton
will help us understand the molecular mechanism underlying
decidualization in vivo and in vitro.\.
 |
Acknowledgments
|
|---|
We are grateful to Dr. Tetsuro Takamatsu, Department of
Pathology and Cell Regulation, Kyoto Prefectural Medical School, for
his technical support and allowing us to access the confocal laser
scanning microscope (Olympus Corp. LSM-GB) in his
laboratory. We are greatly indebted to Dr. Valerie Horn for her
critical reading of this manuscript. Special thanks are given to Dr.
Junji Yodoi for his encouragement and generous support. We deeply thank
Dr. Yuki Kitaoka and his colleagues, Department of Obstetrics and
Gynecology, Kyoto National Hospital, for their cooperation in
collecting tissue samples.
 |
Footnotes
|
|---|
1 Present address: Laboratory of Molecular Growth Regulation (T.M.),
National Institute of Child Health and Human Development, National
Institutes of Health, Building 6, Room 2A11, Bethesda, Maryland 20892. 
2 Present address: Department of Molecular Biology (H.S.), Osaka
Bioscience Institute, Furuedai, Suita, Osaka 565-0874, Japan. 
Received May 3, 1999.
 |
References
|
|---|
-
Hynes RO 1992 Integrins: versatility,
modulation, and signaling in cell adhesion. Cell 69:1125[CrossRef][Medline]
-
Burridge K, Chrzanowska-Wodnicka M 1996 Focal
adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12:463518[CrossRef][Medline]
-
Yamada KM, Miyamoto S 1995 Integrin transmembrane
signaling and cytoskeletal control. Curr Opin Cell Biol 7:681689[CrossRef][Medline]
-
Thomas SM, Brugge JS 1997 Cellular functions
regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513609[CrossRef][Medline]
-
Hanks SK, Polte TR 1997 Signaling through focal
adhesion kinase. BioEssays 19:137145[CrossRef][Medline]
-
Damsky C, Sutherland A, Fisher S 1993 Extracellular matrix 5: adhesive interactions in early mammalian
embryogenesis, implantation, and placentation. FASEB J 7:13201329[Abstract]
-
Sueoka K, Shiokawa S, Miyazaki T, Kuji N, Tanaka M,
Yoshimura Y 1997 Integrins and reproductive physiology: expression
and modulation in fertilization, embryogenesis, and implantation.
Fertil Steril 67:799811[CrossRef][Medline]
-
Yoshimura Y, Miyakoshi K, Hamatani T, Iwahashi K,
Takahashi J, Kobayashi N, Sueoka K, Miyazaki T, Kuji N, Tanaka M 1998 Role of ß1 integrins in human endometrium and decidua during
implantation. Horm Res [Suppl 2] 50:4655
-
Lessey BA, Damjanovich L, Coutifaris C, Castelbaum A,
Albelda SM, Buck CA 1992 Integrin adhesion molecules in the human
endometrium. Correlation with the normal and abnormal menstrual cycle.
J Clin Invest 90:188195
-
Shiokawa S, Yoshimura Y, Nagamatsu S, Sawa H, Hanashi H,
Oda T, Katsumata Y, Koyama N, Nakamura Y 1996 Expression of ß1
integrins in human endometrial stromal and decidual cells. J Clin
Endocrinol Metab 81:15331540[Abstract]
-
Sutherland AE, Calarco PG, Damsky CH 1993 Developmental regulation of integrin expression at the time of
implantation in the mouse embryo. Development 119:11751186[Abstract]
-
Sutherland AE, Calarco PG, Damsky CH 1988 Expression and function of cell surface extracellular matrix receptors
in mouse blastocyst attachment and outgrowth. J Cell Biol 106:13311348[Abstract/Free Full Text]
-
Shiokawa S, Yoshimura Y, Nagamatsu S, Sawa H, Hanashi H,
Koyama N, Katsumata Y, Nagai A, Nakamura Y 1996 Function of beta 1
integrins on human decidual cells during implantation. Biol Reprod 54:745752[Abstract]
-
Ruck P, Marzusch K, Kaiserling E, Horny HP, Dietl J,
Geiselhart A, Handgretinger R, Redman CWG 1994 Distribution of
cell adhesion molecules in decidua of early human pregnancy. An
immunohistochemical study. Lab Invest 71:94101[Medline]
-
Maruyama T, Yoshimura Y, Yodoi J, Sabe H 1999 Activation of c-Src kinase is associated with in vitro
decidualization of human endometrial stromal cells. Endocrinology 140:26322636[Abstract/Free Full Text]
-
Kisalus LL, Herr JC, Little CD 1987 Immunolocalization of extracellular matrix proteins and collagen
synthesis in first-trimester human decidua. Anat Rec 218:402415[CrossRef][Medline]
-
Glasser SR, Lampelo S, Munir MI, Julian JA 1987 Expression of desmin, laminin and fibronectin during in situ
differentiation (decidualization) of rat uterine stromal cells.
Differentiation 35:132142[CrossRef][Medline]
-
Irwin JC, Kirk D, King RJB, Quigley MM, Gwatkin RBL 1989 Hormonal regulation of human endometrial stromal cells in culture:
an in vitro model for decidualization. Fertil Steril 52:761768[Medline]
-
Mulholland J, Aplin JD, Ayad S, Hong L, Glasser SR 1992 Loss of collagen type VI from rat endometrial stroma during
decidualization. Biol Reprod 46:11361143[Abstract]
-
Babiarz B, Romagnano L, Afonso S, Kurilla G 1996 Localization and expression of fibronectin during mouse decidualization
in vitro: mechanisms of cell:matrix interactions. Dev Dyn 206:330342[CrossRef][Medline]
-
Tobe K, Sabe H, Yamamoto T, Yamauchi T, Asai S, Kaburagi
Y, Tamemoto H, Ueki K, Kimura H, Akanuma Y, Yazaki Y, Hanafusa H,
Kadowaki T 1996 Csk enhances insulin-stimulated dephosphorylation
of focal adhesion proteins. Mol Cell Biol 16:47654772[Abstract]
-
Maruyama T, Sachi Y, Furuke K, Kitaoka Y, Kanzaki H,
Yoshimura Y, Yodoi J 1999 Induction of thioredoxin, a redox-active
protein, by ovarian steroid hormones during growth and differentiation
of endometrial stromal cells in vitro. Endocrinology 140:365372[Abstract/Free Full Text]
-
Minamikawa T, Takamatsu T, Fujita S 1991 Application of laser microtomography to in situ three-dimensional
subcellular morphology. Acta Histochem Cytochem 24:5560
-
Miyazaki Y, Takamatsu T, Nosaka T, Fujita S, Hatanaka
M 1992 Intranuclear topological distribution of HIV-1
trans-activators. FEBS Lett 305:15[CrossRef][Medline]
-
Schlaepfer DD, Jones KC, Hunter T 1998 Multiple
Grb2-mediated integrin-stimulated signaling pathways to
ERK2/mitogen-activated protein kinase: summation of both c-Src- and
focal adhesion kinase-initiated tyrosine phosphorylation events. Mol
Cell Biol 18:25712585[Abstract/Free Full Text]
-
Hildebrand JD, Schaller MD, Parsons JT 1995 Paxillin, a tyrosine phosphorylated focal adhesion-associated protein
binds to the carboxyl terminal domain of focal adhesion kinase. Mol
Biol Cell 6:637647[Abstract]
-
Zachary I, Rozengurt E 1992 Focal adhesion kinase
(p125FAK): a point of convergence in the action of
neuropeptides, integrins, and oncogenes. Cell 71:891894[CrossRef][Medline]
-
Clark EA, Brugge JS 1995 Integrins and signal
transduction pathways: the road taken. Science 268:233239[Abstract/Free Full Text]
-
Zachary I, Sinnett-Smith J, Rozengurt E 1992 Bombesin, vasopressin, and endothelin stimulation of tyrosine
phosphorylation in Swiss 3T3 cells. Identification of a novel tyrosine
kinase as a major substrate. J Biol Chem 267:1903119034[Abstract/Free Full Text]
-
Lipfert L, Haimovich B, Schaller MD, Cobb BS, Parsons
JT, Brugge JS 1992 Integrin-dependent phosphorylation and
activation of the protein tyrosine kinase pp125FAK in
platelets. J Cell Biol 119:905912[Abstract/Free Full Text]
-
Chen HC, Guan JL 1994 Stimulation of
phosphatidylinositol 3'-kinase association with focal adhesion kinase
by platelet-derived growth factor. J Biol Chem 269:3122931233[Abstract/Free Full Text]
-
Matsumoto K, Matsumoto K, Nakamura T, Kramer RH 1994 Hepatocyte growth factor/scatter factor induces tyrosine
phosphorylation of focal adhesion kinase (p125FAK) and
promotes migration and invasion by oral squamous cell carcinoma cells.
J Biol Chem 269:3180731813[Abstract/Free Full Text]
-
Rankin S, Rozengurt E 1994 Platelet-derived growth
factor modulation of focal adhesion kinase (p125FAK) and
paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose
response and cross-talk with bombesin. J Biol Chem 269:704710[Abstract/Free Full Text]
-
Tabibzadeh S 1991 Human endometrium: an active site
of cytokine production and action. Endocr Rev 12:272290[Medline]
-
Giudice LC 1994 Growth factors and growth
modulators in human uterine endometrium: their potential relevance to
reproductive medicine. Fertil Steril 61:117[Medline]
-
Lamb NJC, Fernandez A, Conti MA, Adelstein R, Glass DB,
Welch WJ, Feramisco JR 1988 Regulation of actin microfilament
integrity in living nonmuscle cells by the cAMP-dependent protein
kinase and the myosin light chain kinase. J Cell Biol 106:19551971[Abstract/Free Full Text]
-
Tang B, Guller S, Gurpide E 1993 Cyclic adenosine
3',5'-monophosphate induces prolactin expression in stromal cells
isolated from human proliferative endometrium. Endocrinology 133:21972203[Abstract]
-
Telgmann R, Maronde E, Taskén K, Gellersen B 1997 Activated protein kinase A is required for
differentiation-dependent transcription of the decidual prolactin gene
in human endometrial stromal cells. Endocrinology 138:929937[Abstract/Free Full Text]
-
Brar AK, Frank GR, Kessler CA, Cedars MI, Handwerger
S 1997 Progesterone-dependent decidualization of the human
endometrium is mediated by cAMP. Endocrine 6:301307[Medline]
-
Carter CA, Rinehart CA, Bagnell Jr CR, Kaufman DG 1991 Fluorescent laser scanning microscopy of F-actin disruption in
human endometrial stromal cells expressing the SV40 large T antigen and
the EJ ras oncogene. Pathobiology 59:3645[CrossRef][Medline]
-
Kim JJ, Jaffe RC, Fazleabas AT 1999 Insulin-like
growth factor binding protein-1 expression in baboon endometrial
stromal cells: regulation by filamentous actin and requirement for de
novo protein synthesis. Endocrinology 140:9971004[Abstract/Free Full Text]
-
Hatayama H, Kanzaki H, Iwai M, Kariya M, Fujimoto M,
Higuchi T, Kojima K, Nakayama H, Mori T, Fujita J 1994 Progesterone enhances macrophage colony-stimulating factor production
in human endometrial stromal cells in vitro. Endocrinology 135:19211927[Abstract]
This article has been cited by other articles:

|
 |

|
 |
 
T. Nagashima, T. Maruyama, H. Uchida, T. Kajitani, T. Arase, M. Ono, H. Oda, M. Kagami, H. Masuda, S. Nishikawa, et al.
Activation of SRC Kinase and Phosphorylation of Signal Transducer and Activator of Transcription-5 Are Required for Decidual Transformation of Human Endometrial Stromal Cells
Endocrinology,
March 1, 2008;
149(3):
1227 - 1234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ihnatovych, W. Hu, J. L. Martin, A. T. Fazleabas, P. de Lanerolle, and Z. Strakova
Increased Phosphorylation of Myosin Light Chain Prevents in Vitro Decidualization
Endocrinology,
July 1, 2007;
148(7):
3176 - 3184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sakai, T. Maruyama, R. Sakurai, H. Masuda, Y. Yamamoto, A. Shimizu, I. Kishi, H. Asada, S. Yamagoe, and Y. Yoshimura
Involvement of Histone Acetylation in Ovarian Steroid-induced Decidualization of Human Endometrial Stromal Cells
J. Biol. Chem.,
May 2, 2003;
278(19):
16675 - 16682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yamamoto, T. Maruyama, N. Sakai, R. Sakurai, A. Shimizu, T. Hamatani, H. Masuda, H. Uchida, H. Sabe, and Y. Yoshimura
Expression and subcellular distribution of the active form of c-Src tyrosine kinase in differentiating human endometrial stromal cells
Mol. Hum. Reprod.,
December 1, 2002;
8(12):
1117 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|